Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first ... and Takeda Pharma’s α4β7 inhibitor Entyvio (vedolizumab), both of which are ...

Despite major advances in therapies – including, for example, the launch of Takeda's first-in-class integrin inhibitor Entyvio ... the treatment landscape for IBD," remarked Awny Farajallah ...

Also this year, to further support differentiation in IBD, a study comparing Skyrizi to Entyvio in ulcerative ... the first c-Met-directed ADC for the treatment of non-small cell lung cancer.

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...